CTMX

CytomX TherapeuticsC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

Current thesis

The constructive case is that March data and management commentary kept Varseta-M positioned as the core value driver, with FDA interaction targeted for mid-2026, additional follow-up data in 2026, and a newly bolstered capital base after the March equity raise [#PR-2026-03-16] [#8-K-2026-03-19].

Posture

Mixed

Lead driver

Sentiment

What changed

Sentiment remains the lead driver in the composite, 7D delta +15.8.

What can break

2025 revenue declined as collaboration obligations rolled off or progressed differently, highlighting dependence on partners and making internal pipeline execution more important [#PR-2026-03-16].

Momentum

Value

Sentiment

100

Setup hits (3d)

0 · Net Neutral

AI TargetsBase $4.80 · Bull $7.00 · Bear $2.60

Data freshness

Prices

As of 2026-06-02

Fundamentals

As of 2026-06-01 • Vendor: Data Vendor v1

Scores

As of 2026-06-02 • Model: HYBRID_IC_RP

AI Memo

As of 2026-05-05 • Model: RankAlpha Sentiment Codex

Investment thesis

As of 2026-06-02

Supporting evidence

What

Grade C · Mixed

Confidence Medium · Net Neutral

Target $9.00

Why

Momentum8 · Δ7d -1.2

Value53 · Δ7d +0.4

Sentiment100 · Δ7d +15.8

So what

Balanced signals (Net Neutral). Wait for confirmation before sizing up.

Lead driver: Sentiment · See AI snapshot

Momentum

34% active weight

Current posture

7d trendSoftening

Δ7d

-1.2

Δ21d

-9.3

Value

32% active weight

Current posture

7d trendFlat

Δ7d

+0.4

Δ21d

+0.8

Sentiment

100

33% active weight

Current posture

7d trendImproving

Δ7d

+15.8

Δ21d

+25.1

Why this grade

Composite grade C. Momentum 8.3 / Value 53.1 / Sentiment 100.0

Fundamentals (TTM)

As of 2026-06-01

Market Cap

$751.08M

Beta

2.44

Shares Out

169.44M

P/E (TTM)

10.2

P/S (TTM)

6.14

P/FCF (TTM) · Derived

-7.15

Rev YoY

-82.2%

EPS YoY

-228.1%

Gross Margin

Op Margin

+20.5%

Net Debt

-$100.62M

Current Ratio

3.64

As of 2026-06-02 • Updated nightlySource: Internal modelMethodology